FDA Adverse Event Injury Summary report: N

MYNX VASCULAR CLOSURE DEVICE 6F/7F

MDR report key: 2853129 · Received July 10, 2012

Report

Report Number
3004939290-2012-00193
Event Type
Injury
Date Received
July 10, 2012
Date of Event
January 6, 2012
Report Date
June 11, 2012
Manufacturer
ACCESSCLOSURE, INC.
Product Code
MGB
PMA / PMN Number
P040044
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED; THEREFORE, A PHYSICAL INVESTIGATION COULD NOT BE PERFORMED. BASED ON THE INFO PROVIDED, THE MOST LIKELY CAUSE OF THE REPORTED TRANSFUSION WAS HEMATOMA. A REVIEW OF THE LHR WAS NOT POSSIBLE AS THE LOT NUMBER WAS NOT PROVIDED.

Description of Event or Problem · 1

IT WAS REPORTED BY THE ACI VASCULAR CLOSURE SPECIALIST THAT A PT UNDERWENT A LEFT CARDIAC CATHETERIZATION PROCEDURE ON (B)(6) 2012. ACCESS WAS OBTAINED AT THE RIGHT FEMORAL ARTERY. THE PT WAS ANTICOAGULATED WITH EFFIENT, ANGIOMAX, INTEGRILIN, ASA, AND HEPARIN. FOLLOWING THE PROCEDURE, THE PHYSICIAN, SELECTED THE MYNX VASCULAR CLOSURE DEVICE TO CLOSE THE ACCESS SITE. IT WAS REPORTED THAT THE SHEATH WAS PULLED AND THE MYNX DEVICE WAS DEPLOYED. PRESSURE WAS APPLIED FOR 5 MINS AND HEMOSTASIS WAS ACHIEVED. THE PT'S RIGHT GROIN WAS DOCUMENTED AS UNREMARKABLE AND NO BLEEDING WAS NOTED IN ALL OF THE NEUROVASCULAR CHECKS. THE PT'S HGB WAS 9.5 PRE-CATHETERIZATION AND WENT DOWN TO 8.4 WITHIN A 72 HOUR PERIOD FOLLOWING THE CATHETERIZATION PROCEDURE. THE PHYSICIAN DOCUMENTED A "MILD" HEMATOMA ON THE PT'S RIGHT GROIN ON (B)(6) 2012. THE PT RECEIVED 2 UNITS OF PRBCS ON (B)(6) 2012. THERE WAS NO DOCUMENTED ACTIVE GI BLEEDING, DURING THE HOSPITALIZATION PRIOR TO THE CATHETERIZATION/PCI PROCEDURES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MYNX VASCULAR CLOSURE DEVICE 6F/7F MGB ACCESSCLOSURE, INC. MX6700 UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention EFFIENT| ANGIOMAX| HEPARIN| INTEGRILLIN| ASA